'... setron': are 5-HT3 receptor antagonists different?
Aapro
M S
MS
Cancer Center, Clinique de Genolier, Switzerland.
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D005260:Female; D017829:Granisetron / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008297:Male; D017294:Ondansetron / Q000627:therapeutic use; D011985:Receptors, Serotonin / Q000187:drug effects*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D000077526:Tropisetron; D014839:Vomiting / Q000139:chemically induced
D000932:Antiemetics; D000970:Antineoplastic Agents; D017829:Granisetron; D007211:Indoles; D017294:Ondansetron; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D000077526:Tropisetron